Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc. is a Canada-based fully integrated biopharmaceutical company. The Company is focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. The Company has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:AUPH)

Aurinia Pharma Shares Open 100% Higher on Phase 3 Lupus Data

Streetwise Reports December 7, 2019

Bullboard Posts (NDAQ:AUPH)

(AUPH) Investment Analysis and Advice

News; $AUPH (AUPH) Investment Analysis and Advice2024-02-18 11:16:00 ET Stock Traders Daily has produced this trading report using a...
whytestocks - February 18, 2024

Aurinia Pharmaceuticals Finds No Buyer After Strategic Busin

Just In: $AUPH Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback | BenzingaAurinia...
whytestocks - February 15, 2024

Insider Buying

Caught this at the end of today's trading: https://https://newsfilter.io/a/f3900452b2cccee8cead342dda3d2a24m---statement-of...
Apostata - December 15, 2021

More good results

Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults...
ZoranSto - December 9, 2021

RE:RE:RE:WTH ? Happened today ?

New suitor reported again. Short term price changes are just games with the shorts, they have beat this thing hard and won't let it...
jboom70 - December 4, 2021

RE:RE:WTH ? Happened today ?

I also see there was a shite load of insider sales in November , That is not a good sign.
TheRainman - November 22, 2021